Search:
   

Wednesday, September 16, 2015

Equity Trader Alert #2015 - 147
Reverse Split, CUSIP Change, and Ratio Change for Celsus Therapeutics Plc. (CLTX)

Category:

  • Industry Announcement

Markets Impacted:

Contact Information:

Celsus Therapeutics Plc (CLTX) will effect a one for ten (1-10) reverse split of its outstanding American Depositary Shares (“ADS”), and a ratio change of the ADS from one ADS representing ten Ordinary Shares to one ADS representing 100 Ordinary Shares. The changes will become effective at the opening of business on Thursday, September 17, 2015. In conjunction with the reverse split, the CUSIP number will change to 15119A301.

If you would like to register as a market maker in CLTX contact Nasdaq Trade Desk at +1 212 231 5100.

Please follow Nasdaq on Facebook RSS and Twitter.

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $13 trillion. To learn more, visit: business.nasdaq.com.

View NASDAQTrader.com Mobile